KLRK1 and lung carcinoma: Based on these studies, soluble NKG2D ligands may be a new promising liquid biomarker in lung cancer, both as a prognostic level as well as predictive biomarker to standard checkpoint inhibitors and potentially novel sNKG2D ligand targeting approaches.